Progress toward virtual screening for drug side effects

Proteins: Structure, Function and Genetics

Volumn 48, Issue 4, 2002, Pages 664-671

  Rockey, William M ^a   Elcock, Adrian H ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; GUANOSINE DIPHOSPHATE; HYMENIALDISINE; IMATINIB; PROTEIN KINASE INHIBITOR; PURVALANOL A; UNCLASSIFIED DRUG;

ACCURACY; ALGORITHM; ARTICLE; BINDING KINETICS; CALCULATION; CRYSTAL STRUCTURE; DRUG DOCKING ALGORITHM; DRUG INDUCED DISEASE; DRUG RECEPTOR BINDING; DRUG TARGETING; ELECTRICITY; ENERGY; ENZYME ACTIVE SITE; PRIORITY JOURNAL; RELIABILITY; SCREENING; SIMULATION;

ADENOSINE DIPHOSPHATE; ALGORITHMS; AZEPINES; BINDING SITES; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DRUG DELIVERY SYSTEMS; ELECTROSTATICS; ENZYME INHIBITORS; GUANOSINE DIPHOSPHATE; MODELS, MOLECULAR; PIPERAZINES; PROTEIN BINDING; PROTEIN KINASES; PYRIMIDINES; PYRROLES; RECEPTORS, DRUG; RECEPTORS, PURINERGIC P2; SENSITIVITY AND SPECIFICITY;

EID: 0036720460     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/prot.10186     Document Type: Article

References (33)

1. A revolution in R&D: The impact of genomics
2. Cyclooxygenase selectivity and the risk of gastrointestinal complications of various non-steroidal anti-inflammatory drugs: A clinical consideration
3. Molecular modeling and computer aided drug design: Examples of their applications in medicinal chemistry
4. Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors
5. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics
6. Structure-based strategies for drug design and discovery
7. Computational approaches to structure-based ligand design
8. Deciphering common failures in molecular docking of ligand-protein complexes
9. Accommodating protein flexibility in computational drug design
10. Efficient electrostatic solvation model for protein-fragment docking
11. Detailed analysis of scoring functions for virtual screening
12. New treatment for chronic myelogenous leukemia
13. Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule
14. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function
15. Intracellular targets of cyclin-dependent kinase inhibitors: Identification by affinity chromatography using immobilised inhibitors
16. Inhibitor binding to active and inactive CDK2: The crystal structure of CDK2-cyclin A/indirubin-5-sulphonate
17. Molecular approaches to receptors as targets for drug discovery
18. The Protein Data Bank
19. PQS a protein quaternary structure file server
20. WHAT-IF - A molecular modeling and drug design program
21. Optimizing the hydrogen-bond network in Poisson-Boltzmann equation-based pK(a) calculations
22. All-atom empirical potential for molecular modeling and dynamics studies of proteins
23. PRODRG: A program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules
24. High throughput docking for library design and library prioritization
25. Inhibition of cyclin-dependent kinases, GSK-3 beta and CK1 by hymenialdisine, a marine sponge constituent
26. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors
27. Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase
28. Advances in comparative protein-structure modelling
29. The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000
30. Protein modelling for all
31. Potent and selective inhibitors of the Abl-kinase: Phenylaminopyrimidine (PAP) derivatives